These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37851459)

  • 41. Minocycline for acne vulgaris: efficacy and safety.
    Garner SE; Eady EA; Popescu C; Newton J; Li WA
    Cochrane Database Syst Rev; 2003; (1):CD002086. PubMed ID: 12535427
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oral isotretinoin for acne.
    Costa CS; Bagatin E; Martimbianco ALC; da Silva EM; Lúcio MM; Magin P; Riera R
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD009435. PubMed ID: 30484286
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-Term Safety Profile and Off-Label Use of JAK Inhibitors in Dermatological Disorders.
    Corbella-Bagot L; Riquelme-McLoughlin C; Morgado-Carrasco D
    Actas Dermosifiliogr; 2023 Oct; 114(9):784-801. PubMed ID: 37331618
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Major adverse cardiovascular events in patients with atopic dermatitis treated with oral Janus kinase inhibitors: a systematic review and meta-analysis.
    Ertus C; Scailteux LM; Lescoat A; Berthe P; Auffret V; Dupuy A; Oger E; Droitcourt C
    Br J Dermatol; 2023 Sep; 189(4):368-380. PubMed ID: 37410552
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interventions for acne scars.
    Abdel Hay R; Shalaby K; Zaher H; Hafez V; Chi CC; Dimitri S; Nabhan AF; Layton AM
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD011946. PubMed ID: 27038134
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-Term Safety Profile and Off-Label Use of JAK Inhibitors in Dermatological Disorders.
    Corbella-Bagot L; Riquelme-McLoughlin C; Morgado-Carrasco D
    Actas Dermosifiliogr; 2023 Oct; 114(9):T784-T801. PubMed ID: 37543140
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne.
    Liu H; Yu H; Xia J; Liu L; Liu GJ; Sang H; Peinemann F
    Cochrane Database Syst Rev; 2020 May; 5(5):CD011368. PubMed ID: 32356369
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial.
    Reich K; Teixeira HD; de Bruin-Weller M; Bieber T; Soong W; Kabashima K; Werfel T; Zeng J; Huang X; Hu X; Hendrickson BA; Ladizinski B; Chu AD; Silverberg JI
    Lancet; 2021 Jun; 397(10290):2169-2181. PubMed ID: 34023009
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Janus kinase inhibitors for treating active ankylosing spondylitis: a meta-analysis of randomized controlled trials.
    Lee YH; Song GG
    Z Rheumatol; 2022 Feb; 81(1):71-76. PubMed ID: 33340056
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Janus Kinase and Tyrosine Kinase Inhibitors in Dermatology: A Review of Their Utilization, Safety Profile and Future Applications.
    Shalabi MMK; Garcia B; Coleman K; Siller A; Miller AC; Tyring SK
    Skin Therapy Lett; 2022 Jan; 27(1):4-9. PubMed ID: 35081305
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy and Safety of Tofacitinib, Baricitinib, and Upadacitinib for Rheumatoid Arthritis: A Systematic Review and Meta-Analysis.
    Wang F; Sun L; Wang S; Davis JM; Matteson EL; Murad MH; Luo F; Vassallo R
    Mayo Clin Proc; 2020 Jul; 95(7):1404-1419. PubMed ID: 32499126
    [TBL] [Abstract][Full Text] [Related]  

  • 52. JAK inhibitors in the treatment of atopic dermatitis.
    Chovatiya R; Paller AS
    J Allergy Clin Immunol; 2021 Oct; 148(4):927-940. PubMed ID: 34437922
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Emerging systemic JAK inhibitors in the treatment of atopic dermatitis: a review of abrocitinib, baricitinib, and upadacitinib.
    Nezamololama N; Fieldhouse K; Metzger K; Gooderham M
    Drugs Context; 2020; 9():. PubMed ID: 33240390
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Efficacy and safety of new systemic therapies in moderate-to-severe atopic dermatitis in the elderly: meta-analysis].
    Wang SS; Pan XY; Li YN; Li W
    Zhonghua Yi Xue Za Zhi; 2023 Aug; 103(32):2509-2515. PubMed ID: 37650197
    [No Abstract]   [Full Text] [Related]  

  • 55. Minocycline for acne vulgaris: efficacy and safety.
    Garner SE; Eady A; Bennett C; Newton JN; Thomas K; Popescu CM
    Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD002086. PubMed ID: 22895927
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy and safety of dapsone gel for acne: a systematic review and meta-analysis.
    Wang X; Wang Z; Sun L; Liu H; Zhang F
    Ann Palliat Med; 2022 Feb; 11(2):611-620. PubMed ID: 35249339
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combined oral contraceptive pills for treatment of acne.
    Arowojolu AO; Gallo MF; Lopez LM; Grimes DA
    Cochrane Database Syst Rev; 2012 Jul; (7):CD004425. PubMed ID: 22786490
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combined oral contraceptive pills for treatment of acne.
    Arowojolu AO; Gallo MF; Lopez LM; Grimes DA
    Cochrane Database Syst Rev; 2012 Jun; (6):CD004425. PubMed ID: 22696343
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials.
    Guttman-Yassky E; Teixeira HD; Simpson EL; Papp KA; Pangan AL; Blauvelt A; Thaçi D; Chu CY; Hong HC; Katoh N; Paller AS; Calimlim B; Gu Y; Hu X; Liu M; Yang Y; Liu J; Tenorio AR; Chu AD; Irvine AD
    Lancet; 2021 Jun; 397(10290):2151-2168. PubMed ID: 34023008
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Placebo and nocebo responses in randomized controlled trials of non-tumor necrosis factor biologics and Janus kinase inhibitors in patients with active rheumatoid arthritis showing insufficient response to tumor necrosis factor inhibitors: A meta-analysis.
    Sung YK; Lee YH
    Z Rheumatol; 2023 Jan; 82(Suppl 1):59-67. PubMed ID: 34241691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.